Business
Change of Adviser
Change of Adviser.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n Advanced Medical Solutions Grp PLC\n15 August 2007\n\n\n\nFor immediate release 15 August 2007\n\n\n\n Advanced Medical Solutions Group plc\n ('AMS' or 'the Company')\n\n\n Change of Adviser\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global\nmedical technology company, states that following completion of the acquisition\nof Bridgewell Group Plc by Landsbanki Islands hf, the Company is pleased to\nannounce the appointment of Landsbanki Securities (UK) Limited as Nominated\nAdviser and Broker with immediate effect.\n\n\n\n\nFor further information, please contact:\n\nAdvanced Medical Solutions Group plc +44 (0) 01606 545508\nDon Evans, Chief Executive Officer\nMary Tavener, Group Finance Director\nwww.admedsol.com\n\nLandsbanki Securities (UK) Ltd +44 (0) 020 7426 9000\nShaun Dobson, Managing Director\n\nBuchanan Communications +44 (0) 020 7466 5000\nMark Court/Mary-Jane Johnson\n\n\n\n\nNotes to Editors:\n\nAdvanced Medical Solutions is a UK based company developing and providing\nleading edge technology to the $15 billion global woundcare market.\n\nFounded in 1991 and quoted on AIM, the Company is focused on the design,\ndevelopment, manufacture and sale of advanced woundcare dressings and products\nfor closing wounds and sealing tissue.\n\nAMS provides a full range of advanced woundcare products for sale in hospital,\nnursing home and community care markets. The main indications are for chronic\nwounds such as ulcers and pressure sores. These products pioneer the concept of\nmoist wound healing to allow wounds to heal faster and with less pain and\nscarring if they remain moist. They protect the wound, deal with tissue fluids\nand provide an optimal environment for healing to occur. AMS' resources ensure\na unique position as a vertically integrated 'one stop shop' to provide all\ncategories of moist wound healing products. The Company has the capability to\nmove a product from design and development through to production and delivery\nready for distribution into customer markets.\n\nThe acquisition of MedLogic in 2002 has brought AMS products based upon\ncyanoacrylate adhesive technology which allow the closure of wounds following\ntrauma or surgical incisions, or seal skin to protect against breakdown or wound\ninfection. These products address the emerging tissue adhesives and sealants\nsegment...